CTKB
Cytek BioSciences Inc (CTKB)
Healthcare • NASDAQ • $4.61-6.30%
- Symbol
- CTKB
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical Devices
- Price
- $4.61
- Daily Change
- -6.30%
- Market Cap
- $595.35M
- Trailing P/E
- N/A
- Forward P/E
- 76.83
- 52W High
- $6.18
- 52W Low
- $2.37
- Analyst Target
- $6.00
- Dividend Yield
- N/A
- Beta
- 1.23
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitate scientific advances in biomedical research and clinical applications. The company offers Cytek aurora, northern lights systems, and Cytek aurora evo systems delivers cell analysis; Cytek Aurora CS System, a cellular complexity to perform additional downstream genomic and proteomic studies using phenotyping approaches; enhanced small particle detection; Cytek amnis imagestream imaging flow cytometers; Cytek guava muse cell analyzers; Cytek muse micro cell analyzers; Cytek guava easyCyte flow cytometers; and Cytek orion reagent cocktail preparation systems. It also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of i…
Company websiteResearch CTKB on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.